StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research note published on Friday. The firm issued a sell rating on the stock.
Separately, HC Wainwright lifted their target price on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
Check Out Our Latest Stock Report on SenesTech
SenesTech Stock Up 6.7 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- Are Penny Stocks a Good Fit for Your Portfolio?
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- How AI Implementation Could Help MongoDB Roar Back in 2025
- 3 Fintech Stocks With Good 2021 Prospects
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.